EyePod

Thomas Brunner, president & CEO, Glaucoma Research Foundation, San Francisco, CA, shares his thoughts on how living through a pandemic has influenced and altered his perspective on life — both personally and professionally — for the better. 

Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings.

Ophthalmology Times®' Sheryl Stevenson speaks with Marc Mathias, MD, a retinal specialist from Children’s Hospital Colorado, who offers insight on managing cases of inherited retinal dystrophies in pediatric patients, as well as an update on the rapidly changing treatment landscape, thanks to ongoing clinical trials in novel IRD and genetic therapies.

Peter J. Polack, MD, FACS, and Zora Harrison, COO at Ocala Eye in North Central Florida, share the protocols and technology their practice implemented throughout the pandemic that has enabled them to safely and efficiently treat their patients.

Mary Elizabeth Hartnett, MD, FACS, FARVO, a distinguished professor in Ophthalmology and Visual Sciences, University of Utah, as well as director of Pediatric Retina at the John A. Moran Eye Center, and Mark Breazzano, MD, a vitreous and retinal surgeon at the Wilmer Eye Institute, Johns Hopkins University, analyze two areas of AMD relevant to today's field:

Dr. Hartnett highlights current research being conducted on the pathophysiology of AMD involving very long chain polyunsaturated fatty acids and new mechanism for fibrosis and neovascular AMD.   Dr. Breazzano discusses how the COVID-19 pandemic has altered how ophthalmologists treat wet AMD, and how physicians can maximize their patient outcomes. 

Sahar Bedrood, MD, PhD, a glaucoma/cataract specialist at Acuity Eye Group (Pasadena, CA), and a clinical assistant professor at USC Roski Eye Institute, shares her clinical perspective on the multi-faceted, dynamic evolution of interventional glaucoma. 

John H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his experience. 

Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Anne L. Coleman, MD, PhD, president of the American Academy of Ophthalmology (AAO), offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15 —including: in-depth information and innovations, free entry to the 17th annual Orbital Gala, open access to all 8 subspecialty days, new innovations, a first-ever talent show, extended access to content, and much more.